Revive Innovations + Limited designs and manufactures a compact, pre‑filled adrenaline auto‑injector Sign up to read more
Profile updated Jun 2026
| Allotment | Filed | Share Class | Round Size | Round Type |
|---|---|---|---|---|
2024-11-15 | £120k |
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| ABHISHEIK KAMAL | ORDINARY | 50,000 | 38.3% |
| 8888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 88888888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 888888888888888888 | 8888888888 | 888888 | 8888 |
| 8888888888888 | 88888888 | 888888 | 8888 |
Companies with the most similar business descriptions.
Capital raised per employee divides the equity REVIVE INNOVATIONS + LIMITED raised in the last six months by the headcount in its most recent filed accounts. It is a rough read on how capital-intensive the business is: a high figure means the company is raising a lot relative to the number of people it employs, which is typical of hardware, biotech and other research-heavy businesses. Headcount comes from annual accounts and so lags the funding date, often by a year or more.
| 88888888 |
| 888888 |
| 8888 |
6 more shareholders on file , sign up free to see.